If you are coming from another medication and wondering about the transition, the semaglutide withdrawal symptom guide and switching medication guide address what happens when transitioning between different GLP-1 agonists
This is the most commonly reported type in semaglutide case studies
The anti-atherosclerotic effect of active forms was cancelled by exendin(939) or Pro3(GIP)specific antagonists for GLP-1 and GIP receptors
It is administered to adults who : have a Body Mass Index (BMI) 30 kg/m (obesity) have a BMI 27 kg/m but 30 kg/m (overweight), with accompanying weight-related conditions (such as diabetes, high blood pressure, abnormal levels of fats in the blood, respiratory problems during sleep, such as obstructive sleep apnea or a history of heart attack, stroke, or blood vessel problems)
Semaglutide is often prescribed by doctors for patients who have a high body mass index (BMI) or other health conditions related to weight, such as type 2 diabetes